Drug Allergy — Causes, Symptoms, Diagnosis & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

A drug allergy is an immune-mediated adverse reaction to a medication, distinct from non-immunological side effects (e.g., nausea from opioids) and toxic reactions (e.g., paracetamol overdose). True drug allergies involve IgE-mediated (immediate hypersensitivity — anaphylaxis, urticaria) or non-IgE mechanisms (delayed T-cell hypersensitivity — morbilliform rash, Stevens-Johnson syndrome). Penicillin and related beta-lactam antibiotics are the most commonly implicated drugs, followed by sulfonamides, NSAIDs, anticonvulsants, and chemotherapy agents. Approximately 5-10% of all adverse drug reactions are truly immune-mediated. Drug allergy is clinically significant because it restricts treatment options, leads to use of less-effective or more costly alternatives, and can be life-threatening when anaphylaxis occurs. Accurate documentation of drug allergy — including type of reaction, severity, and timing — is essential because imprecise allergy labelling restricts treatment options unnecessarily and contributes to antimicrobial resistance through the use of broader-spectrum alternative antibiotics when narrow-spectrum agents would have been safe and appropriate.

Drug allergies require prior sensitization — the immune system must have encountered the drug (or cross-reactive compound) previously. IgE-mediated reactions are triggered by drugs acting as haptens (small molecules binding to proteins to become immunogenic). Risk factors include: parenteral or repeated intermittent drug administration (greater sensitization risk than continuous oral dosing), female sex (higher risk of allergic reactions), genetic factors (HLA alleles — HLA-B*5701 for abacavir hypersensitivity; HLA-B*1502 for carbamazepine Stevens-Johnson syndrome in South Asians), viral infections (EBV, HIV, CMV — increase rash risk with aminopenicillins), and atopic disease (risk factor for more severe reactions if sensitized). Cross-reactivity occurs between penicillins and cephalosporins (5-10% cross-reactivity), though extensive cross-reactivity between penicillin and carbapenems is rare (1%).

Immediate reactions (within 1 hour of drug administration): urticaria (hives), angioedema, rhinitis, bronchospasm, and anaphylaxis (hypotension, cardiovascular collapse — life-threatening medical emergency). Accelerated reactions (1-72 hours): urticaria, angioedema. Delayed reactions (more than 72 hours — days to weeks): morbilliform (maculopapular) rash is the most common delayed reaction; serum sickness (fever, arthralgia, lymphadenopathy, urticaria — 1-3 weeks post-exposure); drug reaction with eosinophilia and systemic symptoms (DRESS — fever, extensive rash, lymphadenopathy, end-organ damage; can be fatal); Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN — severe blistering of skin and mucous membranes; TEN mortality up to 30%); fixed drug eruption (recurrent, well-demarcated pigmented lesion at same site); drug-induced lupus.

Diagnosis begins with a detailed drug history: timing of reaction relative to drug administration, clinical features, concurrent medications, prior exposures, and resolution with drug discontinuation. Skin prick testing (SPT) and intradermal testing identify IgE-mediated reactions to penicillin and some other drugs (high negative predictive value for penicillin — less than 1% true allergy after negative skin test). Serum specific IgE (ImmunoCAP) is available for penicillin, muscle relaxants (suxamethonium, rocuronium), and some other drugs. Drug provocation test (DPT — graded dose challenge under medical supervision) is the gold standard for confirming or excluding drug allergy, particularly for low-risk reactions. Patch testing detects delayed-type hypersensitivity (type IV — contact dermatitis). Tryptase measurement (within 1-3 hours of anaphylaxis) confirms mast cell activation.

Immediate management: discontinue the suspected drug immediately. Anaphylaxis: intramuscular epinephrine 0.5 mg (1:1,000 concentration) to the outer thigh — this is the first-line life-saving treatment; IV fluid resuscitation; antihistamines (chlorphenamine IV) and corticosteroids (hydrocortisone IV) are adjuncts but not substitutes for epinephrine. Non-anaphylactic mild reactions: oral antihistamines (cetirizine, loratadine) for urticaria; topical corticosteroids for rash; systemic prednisolone for extensive rash or serum sickness. SJS/TEN: urgent dermatology/ICU input; stop the causative drug; supportive care (wound management, IV fluids, nutritional support); cyclosporin or IV immunoglobulin may be used. Drug desensitization: for patients who require the drug and have no effective alternative (e.g., penicillin in syphilis in pregnancy, platinum-based chemotherapy) — graded incremental dose administration under medical supervision creates temporary tolerance. Ensure thorough documentation of the reaction type, drug, dose, and time course in the medical record for all future prescribers to access and reference appropriately.

Unrecognised drug allergy poses serious and potentially fatal risks. Anaphylaxis to drugs (most commonly penicillin, NSAIDs, and neuromuscular blocking agents) is rapidly fatal without immediate epinephrine — perinoperative anaphylaxis has a mortality of 3-9%. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) — caused most commonly by sulfonamides, anticonvulsants (carbamazepine, lamotrigine, allopurinol), and allopurinol — are life-threatening with TEN mortality of 25-35%; delayed recognition means delayed cessation of the causative drug and worsening skin denudation requiring intensive care. DRESS syndrome causes multi-organ damage (hepatitis, myocarditis, renal failure, interstitial pneumonitis) with mortality of up to 10% even with treatment. Conversely, incorrectly labelling patients as 'penicillin allergic' when they have no true allergy (applies to over 90% of penicillin-labelled patients) leads to use of broader-spectrum antibiotics with higher antimicrobial resistance rates, greater side effects, and increased healthcare costs. Avoiding essential drugs without allergy investigation restricts treatment options and may result in less effective therapy.

Document all drug allergies clearly in the patient's medical record, including the nature of the reaction, severity, and date. Wear a medical alert bracelet for serious drug allergies (penicillin anaphylaxis). Carry two auto-injectable epinephrine pens (EpiPen/Jext) if prior anaphylaxis. Refer to an allergist for formal allergy evaluation — up to 95% of patients labelled 'penicillin allergic' can tolerate penicillin after proper allergy assessment, enabling access to first-line antibiotics. Avoid structurally related drugs (check cross-reactivity profiles). HLA pharmacogenomic testing before initiating abacavir (HIV) or carbamazepine (epilepsy in South Asian or Han Chinese patients) prevents serious drug hypersensitivity reactions. Avoid intermittent re-exposure to sensitizing drugs.

Seek emergency care immediately for signs of anaphylaxis: throat tightening, difficulty breathing, swelling of lips/tongue/face, severe dizziness, fainting, rapid weak pulse, or collapse after taking any medication. Attend an emergency department urgently for any spreading rash with mouth sores, eye redness, skin blistering, or fever (possible SJS/TEN). Consult your GP or allergist for any new rash or reaction occurring within days of starting a new medication. Request allergy evaluation if you have been labelled 'penicillin allergic' — formal testing can safely remove this label in the majority and restore access to first-line antibiotics. Report all suspected drug reactions to your GP or hospital team as soon as possible, even if symptoms have resolved, to enable accurate allergy documentation and future safe prescribing. Formal allergy assessment with skin testing or graded challenge may be needed to clarify the exact nature of the reaction.